Refined diagnostic criteria for the bipolar disorders: phase two of the AREDOC project.


Journal

Acta psychiatrica Scandinavica
ISSN: 1600-0447
Titre abrégé: Acta Psychiatr Scand
Pays: United States
ID NLM: 0370364

Informations de publication

Date de publication:
09 2020
Historique:
accepted: 14 07 2020
entrez: 18 1 2021
pubmed: 19 1 2021
medline: 19 8 2021
Statut: ppublish

Résumé

As limitations exist across DSM criteria sets for defining and differentiating the bipolar disorders generally and their component bipolar I (BP-1) and bipolar II (BP-II) sub-types, we sought to generate empirically based criteria. We formed an international Task Force (TF) comprising members with bipolar disorder expertise, and who recruited 74 patients with a TF-diagnosed bipolar I and 104 with a bipolar II condition (with patients responding to definitional queries and symptom questionnaires), while 33 unipolar depressed patients recruited by the first author also completed the symptom questionnaire. A factor analysis sought to determine granular hypo/manic constructs. The bipolar disorder subjects strongly affirmed a new general definition of a bipolar disorder (capturing both manic and hypomanic episodes). While DSM-5 requires impaired functioning, we established that a high percentage of individuals with a BP-I or a BP-II disorder reported improved functioning and therefore modified this criterion. Analyses identified syptoms with differential high rates in individuals with bipolar disorder and its sub-types (and thus not simply capturing happiness), while a factor analysis generated seven symptom constructs both linked with and differing from DSM-5 bipolar symptom criteria. This second-stage report details a new set of criteria for differentiating the bipolar disorders from unipolar depressive conditions, while arguing for BP-I and BP-II disorders being differentiated principally by the respective presence or absence of psychotic features. Future studies will evaluate whether further modifications are required and examine for differential treatment benefits for those with a BP-I versus a BP-II condition.

Identifiants

pubmed: 33460033
doi: 10.1111/acps.13218
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

193-202

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington, VA: American Psychiatric Association;2020.
World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 11th ed. 2019. https://icd.who.int/
Parker G, Tavella G, Macqueen G et al. Revising Diagnostic and Statistical Manual of mental Disorders, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC project. Aust N Z J Psychiatry 2019; 52: 1173–1182.
Jamison KR, Gerner RH, Hammen C et al. Clouds and silver linings: Positive experiences associated with primary affective disorders. Am. J. Psychiatry 1980;137:198–202.
Judd LL, Akiskal HS, Schettler PJ et al. Psychosocial disability in the course of bipolar I and II disorders: A prospective comparative longitudinal study. Arch. Gen. Psychiatry 2005;62:1322–1330.
Parker GB, Graham RK. Clinical characteristics associated with treatment‐resistant bipolar disorder. J. Nerv. Ment. Dis. 2017;205:188–191.
Goldberg JF, Harrow M. Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: a longitudinal analysis. J. Affect. Disord. 2005;89:79–89.

Auteurs

G Parker (G)

School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.

G Tavella (G)

School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.

T Ricciardi (T)

School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.

D Hadzi-Pavlovic (D)

School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.

M Alda (M)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.

T Hajek (T)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.

D L Dunner (DL)

Center for Anxiety and Depression, Mercer Island, WA, USA.
Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA.

C O'Donovan (C)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.

J K Rybakowski (JK)

Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.

J F Goldberg (JF)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

A Bayes (A)

School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.

V Sharma (V)

Department of Psychiatry, Western University, London, ON, Canada.

P Boyce (P)

Discipline of Psychiatry, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.

V Manicavasagar (V)

School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.
Black Dog Institute Psychology Clinic, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH